A Phase 1, Randomized, Parallel Assignment, Double Blind, Placebo Controlled, Single and Multiple Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of ZT002 in Healthy Participants
This study will comprise a randomized, parallel assignment, double blind, placebo controlled, single and multiple ascending dose, safety, tolerability and pharmacokinetic study of ZT002 in healthy participants.
100 Clinical Results associated with QL Biopharmaceutical Australia Pty Ltd
0 Patents (Medical) associated with QL Biopharmaceutical Australia Pty Ltd
100 Deals associated with QL Biopharmaceutical Australia Pty Ltd
100 Translational Medicine associated with QL Biopharmaceutical Australia Pty Ltd